This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Abbott Laboratories (ABT)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 2.28B 2.58B 5.96B 4.73B
Operating Gains/Losses 18.00M 0.00 1.35B 141.56M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -195.00M -113.00M 36.00M -670.15M
(Increase) Decrease in Inventories -297.00M -154.00M -417.05M -129.62M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -225.00M -436.00M -134.21M 1.79B
(Decrease) Increase In Other Current Liabilities 197.00M -665.00M -1.31B -1.40B
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 315.00M 266.00M 1.08B 1.06B
Net Cash From Continuing Operations 3.68B 3.32B 9.31B 8.97B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 3.68B 3.32B 9.31B 8.97B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.08B -1.14B -1.80B -1.49B
Acquisitions -3.32B -580.00M -1.23B -672.50M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 75.00M 21.00M 2.72M 1.89B
Cash Provided by Financing Activities
Net Cash From Investing Activities -202.00M -3.93B -6.08B 260.83M
Issuance of Debt 0.00 9.00M 14.70B -964.68M
Cash Used for Financing Activities
Issuance of Capital Stock 429.00M 395.00M 1.85B 968.76M
Repayment of Long-Term Debt -577.00M -303.00M -11.07B -3.01B
Repurchase of Capital Stock -2.20B -1.60B -2.36B -77.01M
Payment of Cash Dividends -1.34B -882.00M -3.18B -2.94B
Other Financing Charges, Net 943.00M -4.31B 783.87M 0.00
Net Cash From Financing Activities -2.74B -6.70B 716.09M -6.02B
Effect of Exchange Rate Changes -143.00M -26.00M 40.14M -43.00M
Net Change in Cash & Cash Equivalents 588.00M -7.33B 3.99B 3.16B
ABT News

ABT Abbott Laboratories

Analysts Ratings for ABT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 8 7 8
Moderate Buy 4 4 4 4
Hold 5 5 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

ABT Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs